HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-NOV-18 6N3N TITLE IDENTIFICATION OF NOVEL, POTENT AND SELECTIVE GCN2 INHIBITORS AS TITLE 2 FIRST-IN-CLASS ANTI-TUMOR AGENTS COMPND MOL_ID: 1; COMPND 2 MOLECULE: EIF-2-ALPHA KINASE GCN2,EIF-2-ALPHA KINASE GCN2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 4, COMPND 5 GCN2-LIKE PROTEIN,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA COMPND 6 KINASE 4,GCN2-LIKE PROTEIN; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EIF2AK4, GCN2, KIAA1338; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS GCN2, KINASE, INHIBITOR, ANTI-TUMOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.D.HOFFMAN,J.FUJIMOTO,O.KURASAWA,T.TAKAGI,M.G.KLEIN,G.KEFALA, AUTHOR 2 S.C.DING,D.R.CARY,R.MIZOJIRI REVDAT 3 13-MAR-24 6N3N 1 REMARK REVDAT 2 30-OCT-19 6N3N 1 JRNL REVDAT 1 09-OCT-19 6N3N 0 JRNL AUTH J.FUJIMOTO,O.KURASAWA,T.TAKAGI,X.LIU,H.BANNO,T.KOJIMA, JRNL AUTH 2 Y.ASANO,A.NAKAMURA,T.NAMBU,A.HATA,T.ISHII,T.SAMESHIMA, JRNL AUTH 3 Y.DEBORI,M.MIYAMOTO,M.G.KLEIN,R.TJHEN,B.C.SANG,I.LEVIN, JRNL AUTH 4 S.W.LANE,G.P.SNELL,K.LI,G.KEFALA,I.D.HOFFMAN,S.C.DING, JRNL AUTH 5 D.R.CARY,R.MIZOJIRI JRNL TITL IDENTIFICATION OF NOVEL, POTENT, AND ORALLY AVAILABLE GCN2 JRNL TITL 2 INHIBITORS WITH TYPE I HALF BINDING MODE. JRNL REF ACS MED.CHEM.LETT. V. 10 1498 2019 JRNL REFN ISSN 1948-5875 JRNL PMID 31620240 JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00400 REMARK 2 REMARK 2 RESOLUTION. 3.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 7751 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 408 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1984 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 128.8 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.68000 REMARK 3 B22 (A**2) : 0.68000 REMARK 3 B33 (A**2) : -2.20000 REMARK 3 B12 (A**2) : 0.34000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.434 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.398 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 51.374 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 6N3N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1000238123. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8173 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 8.20 REMARK 200 R MERGE FOR SHELL (I) : 1.29800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM NA CITRATE PH 5.6, 10% PEG 5K REMARK 280 MME, 0.7 M LICL, 3% ETHYLENE GLYCOL, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.18367 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 128.36733 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 96.27550 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 160.45917 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 32.09183 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 64.18367 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 128.36733 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 160.45917 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 96.27550 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 32.09183 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 574 REMARK 465 GLY A 575 REMARK 465 SER A 576 REMARK 465 SER A 577 REMARK 465 GLU A 578 REMARK 465 THR A 579 REMARK 465 GLN A 580 REMARK 465 ARG A 581 REMARK 465 GLN A 582 REMARK 465 PHE A 583 REMARK 465 ARG A 628 REMARK 465 GLN A 629 REMARK 465 GLY A 782 REMARK 465 CYS A 783 REMARK 465 HIS A 784 REMARK 465 GLU A 785 REMARK 465 SER A 786 REMARK 465 GLU A 787 REMARK 465 PRO A 788 REMARK 465 SER A 789 REMARK 465 VAL A 790 REMARK 465 THR A 791 REMARK 465 THR A 792 REMARK 465 GLU A 793 REMARK 465 ALA A 794 REMARK 465 SER A 877 REMARK 465 ALA A 878 REMARK 465 ASP A 879 REMARK 465 SER A 880 REMARK 465 LYS A 881 REMARK 465 GLN A 882 REMARK 465 ASP A 883 REMARK 465 ASP A 884 REMARK 465 GLN A 885 REMARK 465 THR A 886 REMARK 465 GLY A 887 REMARK 465 ASP A 888 REMARK 465 LEU A 889 REMARK 465 ILE A 890 REMARK 465 LYS A 891 REMARK 465 SER A 892 REMARK 465 ASP A 893 REMARK 465 PRO A 894 REMARK 465 SER A 895 REMARK 465 GLY A 896 REMARK 465 HIS A 897 REMARK 465 LEU A 898 REMARK 465 GLU A 899 REMARK 465 GLY A 900 REMARK 465 MET A 901 REMARK 465 VAL A 902 REMARK 465 GLY A 903 REMARK 465 VAL A 912 REMARK 465 GLN A 913 REMARK 465 GLY A 914 REMARK 465 SER A 915 REMARK 465 THR A 916 REMARK 465 LYS A 917 REMARK 465 SER A 918 REMARK 465 ALA A 919 REMARK 465 PHE A 966 REMARK 465 ASP A 967 REMARK 465 ASP A 968 REMARK 465 GLY A 969 REMARK 465 GLU A 970 REMARK 465 PRO A 1004 REMARK 465 GLN A 1005 REMARK 465 MET A 1006 REMARK 465 GLU A 1007 REMARK 465 GLU A 1008 REMARK 465 SER A 1009 REMARK 465 GLU A 1010 REMARK 465 LEU A 1011 REMARK 465 HIS A 1012 REMARK 465 GLU A 1013 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 920 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 601 -73.88 -81.17 REMARK 500 ALA A 626 102.51 65.81 REMARK 500 TYR A 652 -59.88 -126.27 REMARK 500 HIS A 796 -86.81 -100.03 REMARK 500 SER A 808 -137.27 53.30 REMARK 500 ARG A 847 -40.32 77.87 REMARK 500 ASN A 848 42.80 -99.94 REMARK 500 LYS A 850 165.45 179.95 REMARK 500 ALA A 875 17.35 -64.86 REMARK 500 GLU A 946 -70.09 -65.16 REMARK 500 ARG A 955 43.88 -96.95 REMARK 500 PRO A 960 153.35 -47.12 REMARK 500 PRO A 963 176.17 -56.74 REMARK 500 LEU A1000 27.53 -77.23 REMARK 500 PRO A1002 -156.93 -42.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 HIS A 796 TYR A 797 -148.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KA4 A 2500 DBREF 6N3N A 577 657 UNP Q9P2K8 E2AK4_HUMAN 577 657 DBREF 6N3N A 658 1013 UNP Q9P2K8 E2AK4_HUMAN 781 1013 SEQADV 6N3N GLY A 574 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3N GLY A 575 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3N SER A 576 UNP Q9P2K8 EXPRESSION TAG SEQADV 6N3N ALA A 807 UNP Q9P2K8 LYS 807 ENGINEERED MUTATION SEQADV 6N3N ASN A 848 UNP Q9P2K8 ASP 848 ENGINEERED MUTATION SEQADV 6N3N GLU A 899 UNP Q9P2K8 THR 899 ENGINEERED MUTATION SEQADV 6N3N GLU A 904 UNP Q9P2K8 THR 904 ENGINEERED MUTATION SEQRES 1 A 317 GLY GLY SER SER GLU THR GLN ARG GLN PHE SER ARG TYR SEQRES 2 A 317 PHE ILE GLU PHE GLU GLU LEU GLN LEU LEU GLY LYS GLY SEQRES 3 A 317 ALA PHE GLY ALA VAL ILE LYS VAL GLN ASN LYS LEU ASP SEQRES 4 A 317 GLY CYS CYS TYR ALA VAL LYS ARG ILE PRO ILE ASN PRO SEQRES 5 A 317 ALA SER ARG GLN PHE ARG ARG ILE LYS GLY GLU VAL THR SEQRES 6 A 317 LEU LEU SER ARG LEU HIS HIS GLU ASN ILE VAL ARG TYR SEQRES 7 A 317 TYR ASN ALA TRP ILE GLU ASN GLY CYS HIS GLU SER GLU SEQRES 8 A 317 PRO SER VAL THR THR GLU ALA VAL HIS TYR LEU TYR ILE SEQRES 9 A 317 GLN MET GLU TYR CYS GLU ALA SER THR LEU ARG ASP THR SEQRES 10 A 317 ILE ASP GLN GLY LEU TYR ARG ASP THR VAL ARG LEU TRP SEQRES 11 A 317 ARG LEU PHE ARG GLU ILE LEU ASP GLY LEU ALA TYR ILE SEQRES 12 A 317 HIS GLU LYS GLY MET ILE HIS ARG ASN LEU LYS PRO VAL SEQRES 13 A 317 ASN ILE PHE LEU ASP SER ASP ASP HIS VAL LYS ILE GLY SEQRES 14 A 317 ASP PHE GLY LEU ALA THR ASP HIS LEU ALA PHE SER ALA SEQRES 15 A 317 ASP SER LYS GLN ASP ASP GLN THR GLY ASP LEU ILE LYS SEQRES 16 A 317 SER ASP PRO SER GLY HIS LEU GLU GLY MET VAL GLY GLU SEQRES 17 A 317 ALA LEU TYR VAL SER PRO GLU VAL GLN GLY SER THR LYS SEQRES 18 A 317 SER ALA TYR ASN GLN LYS VAL ASP LEU PHE SER LEU GLY SEQRES 19 A 317 ILE ILE PHE PHE GLU MET SER TYR HIS PRO MET VAL THR SEQRES 20 A 317 ALA SER GLU ARG ILE PHE VAL LEU ASN GLN LEU ARG ASP SEQRES 21 A 317 PRO THR SER PRO LYS PHE PRO GLU ASP PHE ASP ASP GLY SEQRES 22 A 317 GLU HIS ALA LYS GLN LYS SER VAL ILE SER TRP LEU LEU SEQRES 23 A 317 ASN HIS ASP PRO ALA LYS ARG PRO THR ALA THR GLU LEU SEQRES 24 A 317 LEU LYS SER GLU LEU LEU PRO PRO PRO GLN MET GLU GLU SEQRES 25 A 317 SER GLU LEU HIS GLU HET KA4 A2500 31 HETNAM KA4 N-{3-[(2-AMINOPYRIMIDIN-5-YL)ETHYNYL]-2,4- HETNAM 2 KA4 DIFLUOROPHENYL}-2,5-DICHLORO-3-(HYDROXYMETHYL)BENZENE- HETNAM 3 KA4 1-SULFONAMIDE FORMUL 2 KA4 C19 H12 CL2 F2 N4 O3 S HELIX 1 AA1 SER A 584 GLU A 589 1 6 HELIX 2 AA2 ARG A 631 ARG A 642 1 12 HELIX 3 AA3 THR A 809 GLN A 816 1 8 HELIX 4 AA4 ASP A 821 LYS A 842 1 22 HELIX 5 AA5 GLN A 922 SER A 937 1 16 HELIX 6 AA6 THR A 943 ARG A 955 1 13 HELIX 7 AA7 ALA A 972 ASN A 983 1 12 HELIX 8 AA8 ASP A 985 ARG A 989 5 5 HELIX 9 AA9 THR A 991 SER A 998 1 8 SHEET 1 AA1 5 PHE A 590 LYS A 598 0 SHEET 2 AA1 5 ALA A 603 ASN A 609 -1 O VAL A 604 N LEU A 596 SHEET 3 AA1 5 CYS A 615 PRO A 622 -1 O TYR A 616 N VAL A 607 SHEET 4 AA1 5 TYR A 797 GLU A 803 -1 O LEU A 798 N ILE A 621 SHEET 5 AA1 5 TYR A 651 ILE A 656 -1 N TRP A 655 O TYR A 799 SHEET 1 AA2 2 ILE A 854 LEU A 856 0 SHEET 2 AA2 2 VAL A 862 ILE A 864 -1 O LYS A 863 N PHE A 855 CISPEP 1 PRO A 1002 PRO A 1003 0 4.31 SITE 1 AC1 15 LEU A 596 ALA A 617 VAL A 618 LYS A 619 SITE 2 AC1 15 LEU A 640 VAL A 649 TYR A 651 MET A 802 SITE 3 AC1 15 GLU A 803 TYR A 804 CYS A 805 PHE A 855 SITE 4 AC1 15 GLY A 865 ASP A 866 PHE A 867 CRYST1 82.117 82.117 192.551 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012178 0.007031 0.000000 0.00000 SCALE2 0.000000 0.014062 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005193 0.00000